AzTrials
AzTrials

Cognitive DisorderVR4ICNCT06597591

Virtual Reality Training for Inhibitory Control in Neurocognitive Disorders

A study testing VR headset and Tablet in people with Cognitive Disorder, run by Centre Hospitalier Universitaire de Nice at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Executive function disorders, such as inhibitory control (IC) difficulties, are very common in older adults with neurocognitive disorders (NCD). Management of these disorders is possible using traditional tools and tools based on new technologies, such as serious games and virtual reality (VR). Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Cognitive Disorder
What is being tested?
VR headset and Tablet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteFrance
Study dates
18 Nov 2024to 18 Nov 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • consulting the Nice hospital Memory Center
  • diagnosis of Mild Neurocognitve Disorder or slight major neurocognitive disorder (DSM V)
  • 60 years old or more
  • presence of deficits in inhibitory control as assessed by the Frontal Assessment Battery
  • fluent in French
  • able to understand the informed consent form and voluntarily consents to participate

Who cannot join

  • presence of significant vision or motor problems which would impact ability to perform the task
  • significant self-reported motion sickness
  • vulnerable persons as defined in articles L1121-5 to 8 of the French Public Health Code

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Lemaire Justine contact

+330492034778

lemaire.j@chu-nice.fr

France1 site, 1 recruiting
  • CHU de Nice

    Nice, 06000

    Valérie Foussat, +330493034011, foussat.v@chu-nice.fr

    Recruiting

Other trials in France

About this study

Official title: Acceptability of a VR-based Training for Inhibitory Control in Subjects With Neurocognitive Disorders

Executive function disorders, such as inhibitory control (IC) difficulties, are very common in older adults with neurocognitive disorders (NCD). Management of these disorders is possible using traditional tools and tools based on new technologies, such as serious games and virtual reality (VR). However, today, few immersive tools exist that are specifically focused on IC training. The present study aims to evaluate the acceptability of an immersive application focused on IC in 48 patients with neurocognitive disorders. Participants that will test either an immersive (VR-headset) or a non-immersive (tablet) version of the application for 4 weeks, twice a week, and fill-in acceptability related questionnaires before, during and after the end of the intervention.

Being tested
VR headset, Tablet
Keywords
inhibitory control, serious game, virtual reality, cognitive disorder
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR headsetDevice

    8 sessions (2 times per week for 4 weeks) of 20 minutes playing the serious game with a VR Headset. The serious game is inspired by the GoNoGo task.The players' task is to throw objects in a basket matching the active rule. These objects can be of three different colors (red, yellow, and purple) with the presence or absence of stains on them. The objects' color is hidden until the player interacts with them. Example of rule: the active rule is to throw in the basket only the objects in red without stains, yellow with stains, and purple with stains. To earn points, the player must match the rule presented and throw the objects away if they do not match.

  • TabletDevice

    8 sessions (2 times per week for 4 weeks) of 20 minutes playing the serious game with a tablet. The serious game is inspired by the GoNoGo task.The players' task is to throw objects in a basket matching the active rule. These objects can be of three different colors (red, yellow, and purple) with the presence or absence of stains on them. The objects' color is hidden until the player interacts with them. Example of rule: the active rule is to throw in the basket only the objects in red without stains, yellow with stains, and purple with stains. To earn points, the player must match the rule presented and throw the objects away if they do not match.

Study groups in NCT06597591
Study groupRoleWhat they receive
Serious game on VR headset ( immersive VR)ExperimentalAfter enrolment, patients will have 8 sessions (2 times per week for 4 weeks) of 20 minutes playing the serious game with a VR Headset.
Receives: Device: VR headset
Serious game on tablet ( non Immersive VR)ExperimentalAfter enrolment, patients will have 8 sessions (2 times per week for 4 weeks) of 20 minutes playing the serious game on a tablet.
Receives: Device: Tablet
Waiting Serious game on VR headset (Waiting immersive VR)Experimental2-month after enrolment, patients will have 8 sessions (2 times per week for 4 weeks) of 20 minutes playing the serious game with a VR Headset.
Receives: Device: VR headset
Waiting Serious game on tablet ( Waiting non Immersive VR)Experimental2-month after enrolment, patients will have 8 sessions (2 times per week for 4 weeks) of 20 minutes playing the serious game with a VR Headset.
Receives: Device: Tablet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Unified Theory of Acceptance and Use of Technology 2 (UTAUT2) Questionnaire

    Questionnaire of acceptability / acceptance of the tool and its use by professionals based on the Unified Theory of Acceptance and Use Technology.

    The UTAUT2 questionnaire contains 25 questions and evaluates variables including Performance Expectancy, Effort Expectancy, Social Influence, Facility Conditions..

    Each question is measured using a 7-point Likert scale, from 1 (strongly disagree) to 7 (strongly agree).

    Higher scores indicate a better outcome, reflecting greater acceptance and intention to use the technology.

    Measured: at inclusion

  2. UTAUT 2 Questionnaire

    Questionnaire of acceptability / acceptance of the tool and its use by professionals based on the Unified Theory of Acceptance and Use Technology.

    The UTAUT2 questionnaire contains 25 questions and evaluates variables including Performance Expectancy, Effort Expectancy, Social Influence, Facility Conditions.

    Each question is measured using a 7-point Likert scale, from 1 (strongly disagree) to 7 (strongly agree).

    Higher scores indicate a better outcome, reflecting greater acceptance and intention to use the technology.

    Measured: at 4-week

  3. UTAUT 2 Questionnaire

    Questionnaire of acceptability / acceptance of the tool and its use by professionals based on the Unified Theory of Acceptance and Use Technology.

    The UTAUT2 questionnaire contains 25 questions and evaluates variables including Performance Expectancy, Effort Expectancy, Social Influence, Facility Conditions..

    Each question is measured using a 7-point Likert scale, from 1 (strongly disagree) to 7 (strongly agree).

    Higher scores indicate a better outcome, reflecting greater acceptance and intention to use the technology.

    Measured: at 8-week

  4. UTAUT 2 Questionnaire

    Questionnaire of acceptability / acceptance of the tool and its use by professionals based on the Unified Theory of Acceptance and Use Technology.

    The UTAUT2 questionnaire contains 25 questions and evaluates variables including Performance Expectancy, Effort Expectancy, Social Influence, Facility Conditions..

    Each question is measured using a 7-point Likert scale, from 1 (strongly disagree) to 7 (strongly agree).

    Higher scores indicate a better outcome, reflecting greater acceptance and intention to use the technology.

    Measured: at 16-week

  5. UTAUT 2 Questionnaire

    Questionnaire of acceptability / acceptance of the tool and its use by professionals based on the Unified Theory of Acceptance and Use Technology.

    The UTAUT2 questionnaire contains 25 questions and evaluates variables including Performance Expectancy, Effort Expectancy, Social Influence, Facility Conditions..

    Each question is measured using a 7-point Likert scale, from 1 (strongly disagree) to 7 (strongly agree).

    Higher scores indicate a better outcome, reflecting greater acceptance and intention to use the technology.

    Measured: at 20-week

  6. UTAUT 2 Questionnaire

    Questionnaire of acceptability / acceptance of the tool and its use by professionals based on the Unified Theory of Acceptance and Use Technology.

    The UTAUT2 questionnaire contains 25 questions and evaluates variables including Performance Expectancy, Effort Expectancy, Social Influence, Facility Conditions.

    Each question is measured using a 7-point Likert scale, from 1 (strongly disagree) to 7 (strongly agree).

    Higher scores indicate a better outcome, reflecting greater acceptance and intention to use the technology.

    Measured: at 24-week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start18 Nov 2024
  3. Primary completion18 May 2027 (estimated)
  4. Study completion18 Nov 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Pseudo-randomisation (controlling for demographic and clinical features, and previous VR experience)
Masking
None (open label)
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06597591
Sponsor's protocol ID
24-PP-06 VR4IC
Other IDs
Numéro ID RCB: 2024-A01142-45
Acronym
VR4IC
Status last verified
Jun 2026
First submitted
5 Sep 2024
Last updated
18 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VR headset and Tablet in people with Cognitive Disorder, run by Centre Hospitalier Universitaire de Nice at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lemaire Justine (+330492034778, lemaire.j@chu-nice.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Unified Theory of Acceptance and Use of Technology 2 (UTAUT2) Questionnaire (time frame: at inclusion). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in